A Response to Massimo Bonucci’s Editorial: COVID-19 Outbreak: How to Use Current Knowledge to Better Treat Positive Patients

References (1)

1. Massimo Bonucci. COVID-19 Outbreak: How to Use Current Knowledge to better Treat Positive Patients. Eurasian Journal of Medicine and Oncology. DOI: 10.14744/ejmo.2020.40842 2. Natural Bureau of Traditional Chinese Medicine and the Committee on Public Health and Hygiene. Diagnosis of COVID-19 pneumonia and Treatment. [EB/OL]. [2020.01.28] 3. National Bureau of Traditional Chinese Medicine and the Committee on Public Health and Hygiene. Using Qingfeipaidu Decoction as the herbal formula in the Integrated Treatment for COVID19 patients [EB/OL].[2020.01.30].http//wsjk. tj.gov.cn/art/2020/2/8 art_14_70688.html 4. Xu BS, Yas KW, Xu YS. Qingfeipaidu Decoction gives rapid relief in COVID19 patients-Analysis basing on Traditional Chinese Medicine Theories. Zhong ye Journal: 1-2[2020-02-19] http:// kns.cnki.net/kcms/detail/11.2166. R2020216.2004.002.html. 5. Jas J., Tien TT, Yang J. Understand the pharmacological effects of Qingfeipaidu Decoction through Traditional Theories. J Chin Herbal Medicine: 1-7[2020-02-19] http://kns.cnki.net/ kcms/detail/12.1108 6. Choy’s Net. Assimilated reports from the National Health Official Network Feb-Mar 2020. 7. Jiang PF., Li Sn., Peng QH. Analysis of TCM prevention and treatment schemes for COVID19 in various regions of China. http:// kns.cnki.net/kcms/detail/41.1411.R.20200302.1856.010. html(2020) 8. National Bureau of Traditional Chinese Medicine. Diagnosis of COVID19 pneumonia.[EB/OL].[2020.01.28]. http://bgs.satcm. gov.cn/gongzuodongtai/2020-01-28/12585.html 9. Wang RJ, Yang SJ, Xie CG. Clinical Observation of Qingfeipaidu Decoction in the Treatment of Novel Coronavirus Pneumonia. Pharmacology and clinics of Chinese Materia medica. ISSN.1001-859X.CN51-1188/R 10. Dan Y, Lui HY, Gao WW. Activities of essential oils from Asarum heterotropoides against five phytopathogens. J Cro Prot 2010;29:295. 11. Chen CN, Lin PC, Huang KK, Hsu TA (2005) Inhibition of SARSCOV 3C-Like protease activity by Theaflavin-3, 3’-diagallate. eCAM 2:209–15. 12. Lau KM, Lee KM, Koon CM, Cheung CS, Lau CP, et al. (2008) Immunomodulatory and anti-SARS activities of Houttuynia cordata. J Ethnopharmacol 118:79–85. 13. Leung Ping-chung, Chan Chung-lap Ben, Wong Chun-kwok. Clinical Use of Chinese Medicine in the Current COVID-19 Crisis and Related Research Planning. Clinical Research in Infectious Diseases. 2020 (Under review) 14. Chan B, Wong C, Leung P (2020) What can we do for the Personal Protection against the CoVID-19 Infection? ImmunoBoostering Speci